Major stock indexes surged Thursday after delayed Consumer Price Index data came in better than expected, with the blue-chip Dow Jones Industrial Average and benchmark S&P 500 poised to end four-sessi
Eli Lilly has a new pill, called orforglipron, it plans to launch next year.
AI and healthcare momentum remain strong heading into 2026. NVDA, AVGO and LLY stand out as high-growth leaders with earnings power still driving their rallies.
The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity medicatio
Eli Lilly proved the worth of its obesity pill Thursday. A study showed patients who switched to orforglipron mostly kept the weight off.
Stock News Powerball jackpot nears record: Disney (DIS) network reports the Powerball jackpot has risen to an estimated $1.5 billion for Saturday after no winne

Eli Lilly Scores Another Major Win: Time to Buy?

06:53am, Thursday, 18'th Dec 2025
Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the company's lead in this niche of the industry.
In ATTAIN-MAINTAIN, orforglipron achieved the primary and all key secondary endpoints for weight maintenance vs. placebo at 52 weeks following weight loss on Wegovy or Zepbound Participants who switch
Grant Private Wealth Management Inc lifted its position in shares of Eli Lilly and Company (NYSE: LLY) by 118.8% during the undefined quarter, according to the company in its most recent 13F filing wi
Canandaigua National Trust Co of Florida lowered its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 14.0% during the third quarter, according to its most recent Form 13F filing with the Se
Canandaigua National Bank and Trust Co. boosted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 10.2% in the undefined quarter, according to the company in its most recent disclosure with
Assenagon Asset Management S.A. lessened its stake in Eli Lilly and Company (NYSE: LLY) by 61.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commissi
Eli Lilly is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by 20% or more in Canada, the Globe and Mail reported on Wednesday, citing a note to pharmacies iss
Stock News Dalio, Dell back “Trump accounts”: Ray Dalio (Trades, Portfolio) and Barbara Dalio pledged $75 million to seed child “Trump accounts,” joinin
“History suggests Nvidia should modestly beat Eli Lilly over the next roughly two months,” notes a DataTrek analyst — but there are some caveats
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE